Bifalgorithm post · 10 Cancer Treatment Approvals From September 2026 and What They Mean for You · 4. Ameluz Light Therapy for a Common Skin Cancer

FDA Approval

FDA Approval (10 Cancer Treatment Approvals From September 2026 and What They Mean for You · 4. Ameluz Light Therapy for a Common Skin Cancer) — "Approved: Sep…

Ideas in this flowchart

  • FDA approval of Ameluz gel with red-light photodynamic therapy
  • Approved on Sept. 14
  • Approved for superficial basal cell carcinoma
  • First light-based treatment approved by the FDA for a skin cancer
  • Phase 3 trial evidence
  • Lesions fully cleared in about 66% of patients
  • Lesions fully cleared in about 5% of patients receiving placebo
Feed/

FDA Approval

No cover

Channel

10 Cancer Treatment Approvals From September 2026 and What They Mean for You

1 page

"Approved: Sept. 14\n\nAmeluz gel with red-light photodynamic therapy is now approved for superficial basal cell carcinoma, the first light-based treatment the FDA has approved for a skin cancer. In its phase 3 trial, lesions fully cleared in about 66% of patients vs about 5% with placebo."

Flowchart preview
👍
0
0 comments0 shares

Sign in to view and post comments.